Development and evaluation of blood-based prognostic biomarkers for COVID disease outcomes using EpiSwitch 3-dimensional genomic regulatory immuno-genetic profiling
Ewan Hunter(Unknown), J. M. MELLOR(University of Oxford), Dmitri Pchejetski(University of East Anglia), Alexandre Akoulitchev
Cited by 2
Related Papers
Sphingosine Kinase-1 as a Chemotherapy Sensor in Prostate Adenocarcinoma Cell and Mouse Models
|Cancer Research|2005|203
Oxidative Stress–Dependent Sphingosine Kinase-1 Inhibition Mediates Monoamine Oxidase A–Associated Cardiac Cell Apoptosis
|Circulation Research|2006|197
The emerging role of FTY720 (Fingolimod) in cancer treatment
|Oncotarget|2016|174
Overcoming MDR-associated chemoresistance in HL-60 acute myeloid leukemia cells by targeting shingosine kinase-1
|Leukemia|2005|171
Apelin prevents cardiac fibroblast activation and collagen production through inhibition of sphingosine kinase 1
|European Heart Journal|2011|163